FindTrial
Sign In

COMPARISON OF BUTORPHANOL VERSUS MORPHINE AS AN ADDITION TO EPIDURAL ROPIVACAINE FOR POSTOPERATIVE PAIN RELIEF IN UTERUS RELATED SURGERIES

COMPARISON OF BUTORPHANOL VS MORPHINE AS AN ADJUVANT TO EPIDURAL ROPIVACAINE FOR POSTOPERATIVE ANALGESIA IN TOTAL ABDOMINAL HYSTERECTOMY SURGERIES-A PROSPECTIVE RANDOMISED DOUBLE BLINDED STUDY.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/12/038609
Enrollment
40
Registered
2021-12-14
Start date
Unknown
Completion date
Unknown
Last updated
2022-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: 1- Obstetrics

Interventions

Intervention1: BUTORPHANOL AS AN ADJUVANT: DOSE_0.04mg/kg butorphanol(INTRAVENOUS ROUTE) 24hrs Postoperatively. TO COMPARE POSTOPERATIVE ANALGESIC EFFICACY OF BUTORPHANOL WITH MORPHINE Intervention2:

Sponsors

SUDHAS
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1)PATIENTS UNDERGOING ELECTIVE TOTAL ABDOMINAL HYSTERECTOMY SURGERIES. 2)ASA1 AND ASA2

Exclusion criteria

Exclusion criteria: 1)PATIENT NOT WILLING 2)PATIENT HAVING DRUG ALLERGIES TO SPECIFIC DRUG 3)PATIENTS WITH ANY CONTRAINDICATIONS FOR EPIDURAL ANAESTHESIA 4)PATIENTS WITH INTRAOPERATIVE SURGICAL COMPLICATIONS LIKE MASSIVE BLOOD LOSS AND HEMODYNAMIC INSTABILITY 5)PATIENTS WITH SENSORY AND MOTOR DEFICIT 6)ASA3 AND ASA4

Design outcomes

Primary

MeasureTime frame
DURATION AND QUALITY OF POSTOPERATIVE ANALGESIATimepoint: 24HRS—

Secondary

MeasureTime frame
1)NUMBER OF RESCUE ANALGESIA INBETWEEN 2)HAEMODYNAMIC CHANGESTimepoint: 24HRS—

Countries

India

Contacts

Public ContactDRSUDHA S

Pondicherry institute

rkpuduvai@gmail.com8825778958

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026